TBX19 and neoplasm: Flow-cytometric analysis showed the presence of different pituitary lineages (which may originate from the tumor and/or adjacent tissue), as well as enrichment of the TBX19+ (corticotrope) lineage and stem cells (marked by SOX2, CXCR4 and CD133), similar to the patient’s tumor (68).